Jump to content

Talk:Mesalazine

Page contents not supported in other languages.
From Wikipedia, the free encyclopedia

Methaeoglobinaemia

[edit]

"Methaeoglobinaemia" is listed as a side effect. Should this be "Methaemoglobinaemia" (with an "m"), which redirects to Methemoglobinemia? Songdog 15:13, 8 March 2006 (UTC)[reply]

Mesalamine

[edit]

Content moved from mesalamine to mesalazine to reflect the International Nonproprietary Name rather than the United States Approved Name PeteThePill 22:55, 18 Jun 2005 (UTC)

Lialda

[edit]

The section describing Lialda sounds a little bit like a sales pitch for the drug. The other formulations are not really mentioned much, and it seems to be emphasizing benefits of Lialda that don't seem proven yet. I'm just a layperson when it comes to this stuff, so please take my comment with a grain of salt. —Preceding unsigned comment added by 198.135.207.129 (talk) 16:19, 17 January 2008 (UTC)[reply]

Mode of action?

[edit]

How does the drug work? If this is not known, it should be said that such information is unavailable. —Preceding unsigned comment added by 99.238.142.12 (talk) 22:21, 25 August 2008 (UTC)[reply]

Asacol is banned now by the FDA and in several countries due to the presence of dibutyl phthalate, I think it is worth mentioning. The ban also suspeciously comes just as the patent was expiring and the new patent for drug Delzicol came. — Preceding unsigned comment added by 117.192.242.244 (talk) 06:01, 30 January 2014 (UTC)[reply]

Advert?

[edit]

This page supposedly on a generic drug reads like an advert for Apriso — Preceding unsigned comment added by 194.176.105.132 (talk) 17:12, 23 May 2012 (UTC)[reply]

I removed some of the Apriso stuff and reorganized some of the content. -- Ed (Edgar181) 20:32, 24 May 2012 (UTC)[reply]

"PENTASA" listed at Redirects for discussion

[edit]

An editor has asked for a discussion to address the redirect PENTASA. Please participate in the redirect discussion if you wish to do so. Whywhenwhohow (talk) 02:22, 10 December 2019 (UTC)[reply]